2026 NPPES data Specialist NPI 1497856702 M.D.
Verify on CMS →

MARK LIERZ, M.D.

Specialist in SAINT JOSEPH, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
5K
Medicare Part D claims · 1K beneficiaries · Specialist avg: 1K
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
96.6069/100
▲ 14 pts above national avg 83.1 · [object Object]
Industry payments
$547.78
32 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK LIERZ, M.D. is a Specialist ([object Object]) practicing in SAINT JOSEPH, Missouri with a Medicare Part D prescribing footprint of 5K claims across 1K beneficiaries — 18% brand-name prescribing . Their CMS MIPS Final Score of 96.6069/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $547.78 across 32 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK LIERZ, M.D. reported a CMS MIPS final score of 96.6069 out of 100, above the 83.1 national average, and filed 5,463 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

MARK LIERZ, M.D. at a glance

High performer (top quartile)

NPI registry status

Active

Issued 09/26/2006

NPI 1497856702

Primary specialty

Specialist

High-volume

69,658 US NPIs in this specialty

Medicare Part D claims

5,463 271% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

MIPS final score

96.6069/100 13.506900000000002% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Missouri

How Specialist compares to other specialties among Missouri providers

Missouri providers

Specialist share within Missouri

1. Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Specialist share within Missouri

Medicare quality performance — MIPS

MARK LIERZ, M.D.'s 2023 MIPS final score plotted against the Specialist national average

High performer (top quartile)
MIPS Final Score
96.6069/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Specialist) — 96.6069/100 vs national avg 83.1

0%100%National avg83%96.6%
MIPS final score (Specialist) — 96.6069/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK LIERZ, M.D. is a Specialist provider practicing in SAINT JOSEPH, Missouri, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1497856702. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK LIERZ, M.D. appears in the CMS NPPES registry as a Specialist provider holding M.D. credentials at 901 HEARTLAND RD, SAINT JOSEPH, MO, 64506, with a listed phone of (816) 232-8877. NPI 1497856702 was issued on 09/26/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LIERZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 5,463 prescription claims written by this provider, covering 1,138 Medicare beneficiaries and totaling roughly $478K in drug spend, split 18% brand-name and 82% generic by claim count, with an opioid prescribing rate of 1.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 96.6069/100 for the 2023 performance year (Quality 92.2415), compared with the national average of 83.1.

Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

901 HEARTLAND RD
SAINT JOSEPH, MO 64506

Provider Details

NPI 1497856702
Specialty Specialist
Credentials M.D.
Gender Male
NPI Issued 09/26/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

96.6069
Final Score
Avg: 83.1
92.2415
Quality
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK LIERZ, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PHOENIX UROLOGY OF ST JOSEPH INC
ATCHISON, KS

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK LIERZ, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$548

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MARK LIERZ, M.D. — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 5,463 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

5,463
Total Claims
$478K
Total Drug Cost
1,138
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
9,168
Total Day Supply
247,984
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$386K
Generic Drug Cost
$91K
Opioid Claims
91 (1.7% rate)
Antibiotic Claims
1,552

Patient Demographics

Average Patient Age
75.8 years
Avg HCC Risk Score
1.40
Gender Split
32% female / 68% male
Age Distribution
<65: 72, 65-74: 427, 75-84: 469, 85+: 170

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tamsulosin Hcl
1,044
Finasteride
1,042
Ciprofloxacin Hcl
494
Nitrofurantoin
Nitrofurantoin Macrocrystal
452
Myrbetriq
Mirabegron
384
Oxybutynin Chloride
304
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
206
Trimethoprim
190
Gemtesa
Vibegron
155
Dutasteride
136

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How MARK LIERZ, M.D. fits within the Specialist landscape nationally.

69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

MARK LIERZ, M.D.'s 5,463 claims are above the specialty average of 1,474.

Nearby Specialist Providers in Missouri

Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as LIERZ.

Compare Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK LIERZ, M.D.'s specialty?
MARK LIERZ, M.D. specializes in Specialist and practices in SAINT JOSEPH, Missouri. Credentials: M.D..
How much does MARK LIERZ, M.D. prescribe under Medicare Part D?
In 2023, MARK LIERZ, M.D. wrote 5,463 Medicare Part D claims totaling $478K in drug costs for 1,138 beneficiaries.
What is MARK LIERZ, M.D.'s Medicare quality score?
MARK LIERZ, M.D. has a CMS MIPS Final Score of 96.6069/100 (Quality: 92.2415). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK LIERZ, M.D. located?
MARK LIERZ, M.D. is located at 901 HEARTLAND RD, SAINT JOSEPH, MO, 64506. Phone: (816) 232-8877.
What is MARK LIERZ, M.D.'s NPI number?
MARK LIERZ, M.D.'s National Provider Identifier (NPI) is 1497856702, issued on 09/26/2006.
Does MARK LIERZ, M.D. prescribe more brand-name or generic drugs?
MARK LIERZ, M.D.'s prescribing is 18% brand-name and 82% generic drugs by claim count, with $386K in brand drug costs.
Does MARK LIERZ, M.D. prescribe opioids?
Yes, MARK LIERZ, M.D. had 91 opioid claims in 2023 with an opioid prescribing rate of 1.7%.
How many Specialist providers are there in the US?
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does MARK LIERZ, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK LIERZ, M.D.'s most frequently prescribed drugs include Tamsulosin Hcl, Finasteride, Ciprofloxacin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK LIERZ, M.D. accept Medicare?
MARK LIERZ, M.D. appears in CMS Medicare data with 5,463 Part D claims and 1,138 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK LIERZ, M.D.'s credentials?
MARK LIERZ, M.D.'s NPI is 1497856702 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology